iTeos Therapeutics, Inc. - 46565G104
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Description is not available for this instrument yet.
Quarter snapshot
Latest / Compare
Q3 2025
· Q2 2025
Value (USD)
Total reported value ($000)
$3.17M
QoQ value delta ($000)
-$386.6M
(-99.19%)
Implied price effect (QoQ)
-0.03%
Shares
Total shares
318,091
QoQ shares delta
-38,781,029
(-99.19%)
Total shares held by funds (by quarter)
Top holders (Q3 2025)
Top 25 only
Full list
Partial Q3 2025 data: 1 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| ROYAL BANK OF CANADA | 1,852 | 185,760 | 0.0% |
| GABELLI FUNDS LLC | 1,202 | 120,593 | 0.01% |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE | 114 | 11,466 | 0.0% |
| IFP Advisors, Inc | 2 | 232 | 0.0% |
| Allworth Financial LP | 0 | 40 | 0.0% |